ArticlePharmacological research2016

SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing.

Athina Mavrou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.